PATENT CLAIM ANALYSIS

Application Number: 15962333
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to certain thiazolopyrimidinone compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

Claim (Index 64):
A method of treating a subject suffering from or diagnosed with a disease or medical condition mediated by N2RA activity, comprising administering to the subject in need of such treatment an effective amount of at least one compound of any one of  claims 1 - 62 , or a pharmaceutical composition of  claim 63 .

Metadata:
- Claim Count in Document: 243.0
- Percentile: 91.0
- Lexical Diversity: 1.21053
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15094687', '16068559', '10038069', '14735924', '11179458']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7720430210750661
- 35 USC 102 Novelty (BERT): 0.5600913024440348
- Combined Prediction Score: 0.7508478492119629
- Mean Citation Score: 383.932908
- Max Citation Score: 457.0993
- Similarity Product: 301.3050701917052

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test